27 June 2016 - Deborah Wilkes
Archived
Boehringer Ingelheim and Sanofi have now signed contracts for their proposed asset swap, including Sanofi’s acquisition of Boehringer Ingelheim’s Consumer Health Care business. The two companies expect to complete the deals by the end of 2016.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.